Investigators compared lenvatinib plus either pembrolizumab or everolimus versus sunitinib in patients with advanced renal cell carcinoma in the CLEAR trial.According to results from...
A guideline-based model described in The Lancet Oncology may provide a new template for high-income and emerging economies to rationally plan and evaluate their...
Nivolumab (Opdivo) plus cabozantinib (Cabometyx) demonstrated improved efficacy and prolonged survival compared with sunitinib (Sutent) among patients with previously untreated advanced renal cell carcinoma...
Frequent and durable antitumor responses as well as extended survival were noted with the use of larotrectinib (Vitrakvi) in patients with NTRK gene fusion–positive...
The chief of Gastrointestinal Radiation Oncology at the Rutgers Cancer Institute of New Jersey spoke about the possible implications of the KEYNOTE-799 study findings.Pembrolizumab...
Following several common oncologic procedures, patients with a high Social Vulnerability Index (SVI) had a higher greater likelihood of having a complication, extended length...
Focusing the discussion on the risks of adverse events (AEs) with patient goals in mind has the potential to improve communication between oncologists and...
Early results from a phase 2 trial (NCT03019640) showed that cord blood–derived natural killer (NK) immunotherapy plus high-dose chemotherapy and autologous stem cell transplant...
Sequential chemoradiation (SCRT) resulted in a higher disease-free survival (DFS) rate and lower risk of cancer death versus concurrent chemoradiation (CCRT) or radiation (RT)...
The medical oncologist and physician scientist based at the University of Texas MD Anderson Cancer Center explained recommendations for SARS-CoV-2 vaccination in patients participating...
When comparing recurrence scores in the United States, investigators found that Black women were more likely to have a high-risk recurrence score and to...
BioInvent International AB recently announced interim data from a phase 1/2a trial of the antibody BI-1206 in combination with rituximab (Rituxan) to treat patients...
The first single-dose COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the FDA, according to its developer Janssen Pharmaceutical Companies of Johnson &...
In a comparison of systemic treatments as add-ons to androgen-deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), abiraterone acetate (Zytiga) and...
A cross-sectional study of digital breast tomosynthesis (DBT) screening published in JAMA Network Open indicated that women of minority race/ethnicity and lower socioeconomic status...
An analysis revealed that as a third- or fourth-line treatment for RCC, tivozanib significantly increased Q-TWiST compared with sorafenib, primarily through an increase in...
